Acorda Therapeutics, Inc. (ACOR)

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Notable Posts

Loading...

Popular Topics & Highlights

Loading...

Analysis

Yesterday, Saturday, July 24, we saw neutral social sentiment for Acorda Therapeutics, Inc. (ACOR). We gave it a score of 7. There was little activity, such as likes and shares, on social media.

Over the prior 7 days we calculated an average sentiment score of 14 (positive). Over the prior 14 days our AI scored an average sentiment of 15 (positive). And for the prior 30 days our social sentiment score for Acorda Therapeutics, Inc. (ACOR) is 14 (positive).

Related Companies

10x Genomics Inc (TXG)

9 Meters Biopharma Inc. (NMTR)

Acceleron Pharma Inc. (XLRN)

Adaptimmune Therapeutics plc (ADAP)

ADiTx Therapeutics Inc. (ADTX)

ADMA Biologics Inc (ADMA)

Adverum Biotechnologies, Inc. (ADVM)

Agenus Inc. (AGEN)

AIkido Pharma Incorporated (AIKI)

Allena Pharmaceuticals, Inc. (ALNA)

Allogene Therapeutics, Inc. (ALLO)

AlloVir Inc (ALVR)

Amgen Inc. (AMGN)

Applied Genetic Technologies Corporation (AGTC)

Applied Therapeutics Inc. (APLT)

Aptose Biosciences, Inc. (APTO)

argenx SE (ARGX)

Atara Biotherapeutics, Inc. (ATRA)

aTyr Pharma, Inc. (LIFE)

Autolus Therapeutics plc (AUTL)

AVROBIO, Inc. (AVRO)

Axcella Health Inc. (AXLA)

Axovant Gene Therapies Ltd. (AXGT)

Beam Therapeutics Inc. (BEAM)

BELLUS Health Inc. (BLU)

BioCryst Pharmaceuticals, Inc. (BCRX)

Biogen Inc. (BIIB)

BioNTech SE (BNTX)

BioTime, Inc. (BTX)

bluebird bio, Inc. (BLUE)

Brainstorm Cell Therapeutics Inc. (BCLI)

CASI Pharmaceuticals, Inc. (CASI)

Cellectis S.A. (CLLS)

Cel-Sci Corporation (CVM)

Coherus BioSciences, Inc. (CHRS)

Compugen Ltd. (CGEN)

Cortexyme Inc. (CRTX)

CRISPR Therapeutics AG (CRSP)

Curis, Inc. (CRIS)

Dyadic International Inc. (DYAI)

Editas Medicine, Inc. (EDIT)

Eiger BioPharmaceuticals, Inc. (EIGR)

Enlivex Therapeutics Ltd. (ENLV)

Entera Bio Ltd. (ENTX)

Fate Therapeutics, Inc. (FATE)

Fennec Pharmaceuticals Inc. (FENC)

Frequency Therapeutics Inc. (FREQ)

Genetic Technologies Ltd (GENE)

Gilead Sciences, Inc. (GILD)

Gritstone Oncology, Inc. (GRTS)

Heska Corporation (HSKA)

Histogen Inc. (HSTO)

Humanigen Inc (HGEN)

Idera Pharmaceuticals, Inc. (IDRA)

Inmune Bio Inc. (INMB)

Iovance Biotherapeutics, Inc. (IOVA)

IVERIC bio Inc. (ISEE)

La Jolla Pharmaceutical Company (LJPC)

Liminal BioSciences Inc. (LMNL)

Liquidia Technologies, Inc. (LQDA)

Lixte Biotechnology Holdings Inc (LIXT)

LogicBio Therapeutics, Inc. (LOGC)

Mesoblast Limited (MESO)

Mimedx Group Inc (MDXG)

Moderna, Inc. (MRNA)

Momenta Pharmaceuticals, Inc. (MNTA)

Morphic Holding Inc. (MORF)

NantKwest, Inc. (NK)

Neurocrine Biosciences, Inc. (NBIX)

Novavax, Inc. (NVAX)

Ocugen Inc (OCGN)

Orchard Therapeutics plc (ORTX)

Organovo Holdings, Inc. (ONVO)

Outlook Therapeutics, Inc. (OTLK)

Personalis Inc. (PSNL)

Pluristem Therapeutics, Inc. (PSTI)

PolarityTE, Inc. (PTE)

Precigen Inc (PGEN)

Precision BioSciences Inc. (DTIL)

Protalix BioTherapeutics, Inc. (PLX)

Qiagen N.V. (QGEN)

REGENXBIO Inc. (RGNX)

Repligen Corporation (RGEN)

Sangamo Therapeutics, Inc. (SGMO)

Scholar Rock Holding Corporation (SRRK)

Seattle Genetics, Inc. (SGEN)

Seelos Therapeutics Inc. (SEEL)

Solid Biosciences Inc. (SLDB)

Sonnet BioTherapeutics Holdings Inc. (SONN)

Sutro Biopharma, Inc. (STRO)

TRACON Pharmaceuticals, Inc. (TCON)

Translate Bio, Inc. (TBIO)

Twist Bioscience Corporation (TWST)

Vaxart, Inc. (VXRT)

VBI Vaccines, Inc. (VBIV)

Vir Biotechnology Inc. (VIR)

Voyager Therapeutics, Inc. (VYGR)

Windtree Therapeutics Inc. (WINT)

Xtant Medical Holdings, Inc. (XTNT)

Disclaimer

We believe social network activity can help inform investors of the positive and negative opinions people hold of a company. Social media posts are made both before and after market price changes. We can make no claim of causation or future correlation between market prices and social media sentiment. We make no evaluation or predictions of stock value. We do not endorse any posts on social media which are reposted here.

This page is being provided for informational purposes only, and on the condition that it will not form a primary basis for any investment decision. Investors should make their own determination of whether or not to buy or sell a stock based on their specific investment goals, with proper due diligence, and in consultation with their financial advisor. See financial disclosures on our About the Developer page.

We've trained our artificial intelligence systems from past social media posts. While tests show our predictions are usually accurate to our models, a human may come to a different conclusion for some posts.